Metastatic penile carcinoma – an update on the current diagnosis and treatment options
Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 2
Abstract
Introduction Penile carcinoma has an incidence of 4,000 cases in Europe. The therapy and prognosis depend decisively on the lymph node status. Lymph node metastases are detected in 23–65% cases depending on the histopathological pattern. Due to improved diagnostic methods an early detection of tumor stage is possible. Multimodal therapeutic concepts can offer curability for a subset of patients, even those suffering from advanced disease. Material and methods Current data on penile cancer based on a selective review of the literature by PubMed and the EAU guidelines 2009. Results Invasive diagnostic tools, such as fine–needle biopsy (FNB) and dynamic sentinel node biopsy (DSNB), improved the diagnosis of lymph node status considerably and reduced the morbidity in specialized centers. The application of 18F–FDG–PET/CT for metastases detection needs further evaluation due to inconsistent results. Inguinal lymphadenectomy is the therapeutic standard in case of metastases proof. It was possible to reduce the complications due to the new modified operation techniques. Patients with extended lymph node and distant metastases have a poor prognosis. Different systemic polychemotherapy regimes are applied currently and are associated with poor outcome (response rates <50%) and high morbidity. Neoadjuvant chemotherapy is recommended in patients with unresectable and relapsing lymph node metastases. Conclusions Currently, inconsistent therapy regimens are applied for metastatic penile cancer. Standardization is urgently needed through the development of high–quality studies and long–term registers in order to lower the morbidity and increase the efficiency of diagnosis and therapy.
Authors and Affiliations
Dimitri Barski, Evangelos Georgas, Holger Gerullis, Thorsten Ecke
Keywords
Related Articles
- EP ID EP337137
- DOI 10.5173/ceju.2014.02.art2
- Views 54
- Downloads 0
300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
Editorial. The article does not have an abstract.
Management of iatrogenic, post–prostatectomy recto–urinary fistula – not a cut–and–dried debate. Does the best option exist?
Editorial.
Direct mobile phones radiation influence: Dial 1-800-EXTINCTION
Editorial.
Lower urinary tract symptoms and their severity in men subjected to prostate biopsy
Introduction Lower urinary tract symptoms (LUTS) are one of most frequent complaints among men over 50 years of age. They usually result from benign prostate hyperplasia, which often coexists with cancer. The aim of the...
Predicting stone composition before treatment – can it really drive clinical decisions?
Introduction Determination of stone composition is considered to be crucial for the choice of an optimal treatment algorithm. It is especially important for uric acid stones, which can be dissolved by oral chemolysis and...